immuvac
Vaccineexperimental
Clinical trial activity
3 trials · 26 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2007 (NCT00525408)
Timeline
Indications
Mechanism of action
- AngiotensinogenImmunity, active
AGT immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- immuvac
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00810849 | Phase 3 | Dec 1, 2008 | McMaster University, University of Cape Town |
| NCT00680940 | Phase 2 | Jun 1, 2008 | Acharya Tulsi Regional Cancer Treatment & Research Institute, Bankura Sammilani Medical College, B.P. Poddar Hospital and Medical Research Ltd., Cadila Healthcare, Chittaranjan National Cancer Institute, Choithram Hospital and Research Centre, GKNM Hospital, Coimbatore, India, Gujarat Cancer & Research Institute, Indira Ghandhi Institute of Medical Science, Malabar Institute of Medical Sciences, MNJ Cancer Hospital Hyderabad, Netaji Subhash Chandra Bose Cancer Research Institute, Patel Hospital Pvt. Ltd., Postgraduate Institute of Medical Education and Research, R.S.T. Cancer Hospital & Research Centre |
| NCT00525408 | Phase 2 | Nov 1, 2007 | Cadila Healthcare, Chatrapati Sahuji Mahraj Medical University, Choithram Hospital and Research Centre, Christian Medical College, Vellore, India, Kasturba Medical College, Kidwai Memorial Institute of Oncology, Bangalore, LTMMC & LTMGH, Patel Hospital Pvt. Ltd., Postgraduate Institute of Medical Education and Research, Rajiv Gandhi University of Health Sciences, RCC, Trivandrum, Safdarjang Hospital, Seth Gordhandas Sunderdas Medical College |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (26)
26 organizations
Page 1 / 2